Global Podophyllin Market Overview:
Podophyllin is a Resin of a Herbaceous Plant which is Used Mainly for the Destruction of Non-Malignant Growths, & Removal of Genital Warts (Condyloma) as well as Common Warts. It Terminates T=the Growth of Abnormal Tissues. It is on the List of Essential Medicines Prescribed by the World Health Organization (WHO). It is Derived from the Roots of Podophyllin Peltatum or Emodi
Market Drivers
- The rise in the number of patients with different kinds of warts like genital and periungual warts
- Presence of population suffering from HIV/AIDS
Market Trend
- Increasing Adoption of Podophyllin for treating various medical conditions
Restraints
- Presence of alternative substances in the market
Opportunities
- Owing to the rise in research and development in the healthcare industry, there is an increased opportunity for the usage of Podophyllin for primary cancer treatments
- There are prospects for using Podophyllin in immunology & dermatology
Challenges
- Intoxication with Podophyllin results in severe side effects such as vomiting, abdominal pain, confusion, bone marrow suppression, and diarrhea
Competitive Landscape:
The Market for the Podophyllin is fragmented with the Presence of Many Players. Owing to Widespread Usage, there are Growing Prospects for the New Players to Enter the Market
Some of the key players profiled in the report are Andard-Mount Company Ltd. (United Kingdom), LGM Pharma (United States), Carl Roth GmbH + Co. KG (Germany), Himpharm (United States), Xi'an Hao Xuan Biological Technology Co., Ltd (China), Kiaradecor (India), Namiex Chemicals Private Limited (India), Hebei Tongxi Pharmaceutical Co., Ltd. (China), Xa Bc-Biotech Co., Ltd. (China), Organic Herb Inc. (Hunan) (China), Shaanxi Yuantai Biological Technology Co., Ltd. (China) and Xian Aladdin Biological Technology Co., Ltd. (China). Analyst at AdvanceMarketAnalytics see United States and Asian Players to retain maximum share of Global Podophyllin market by 2025. Considering Market by Sales Channels, the sub-segment i.e. Pharmacies will boost the Podophyllin market. Considering Market by Form, the sub-segment i.e. Solid will boost the Podophyllin market.
Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Podophyllin market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Podophyllin market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Podophyllin, Research Organizations, Suppliers, Investors and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.